title: [The survey for anti-emetic guideline by using questioner].
abstract: BACKGROUND
  Japan Society of Clinical Oncology published a guideline for anti-emetic therapy two years ago. This guideline was a first evidence based guideline of anti-emetic treatment for the patients who received chemotherapy in Japan. To investigate a current situation of anti-emetic treatment in Japan, we analyzed the data from nationwide questionnaire.
  
  
  METHODS
  Questionnaire analysis; From June 2012 to August 2012, we gave 24 questionnaires on the Japan Society of Clinical Oncology Website and collected the response from the member of 5 major academic oncology societies. The questionnaires included degree of recognition, penetration, usefulness, problems and user type of medial stuff for the anti-emetic guideline published by (JSCO).
  
  
  RESULTS
  Questionnaire; 1,529 medical stuff responded to our questionnaire. 1,308 (85.5%) stuffs recognized JSCO guidelines, 586 (51%) had regard for guideline and 489 (42.6%) referred to the guideline. 899 (78.3%) changed their practice in clinic to recommended practice by the guideline. But 385 (33.5%) complained high medical cost of recommended anti-emetic therapy.
  
  
  CONCLUSIONS
  Degree of recognition and penetration of our guideline for anti-emetic therapy were very high in Japan.
authors: Dept. of Breast Oncology, International Medical Center, Saitama Medical University.
authors: Toshiaki
authors: T
authors: Saeki
authors: Kazuo
authors: K
authors: Tamura
authors: Keisuke
authors: K
authors: Aiba
authors: Kenjiro
authors: K
authors: Aogi
authors: Keiko
authors: K
authors: Iino
authors: Chiyo
authors: C
authors: Imamura
authors: Kenji
authors: K
authors: Eguchi
authors: Kenji
authors: K
authors: Okita
authors: Yoshikazu
authors: Y
authors: Kagami
authors: Ryuhei
authors: R
authors: Tanaka
authors: Kazuhiko
authors: K
authors: Nakagawa
authors: Hirofumi
authors: H
authors: Fujii
authors: Narikazu
authors: N
authors: Boku
authors: Kazuo
authors: K
authors: Matsuura
authors: Makoto
authors: M
authors: Wada
authors: Tatsuo
authors: T
authors: Akechi
authors: Yuichi
authors: Y
authors: Kakudo
authors: Yong-Il
authors: YI
authors: Kim
authors: Hidenori
authors: H
authors: Sasaki
authors: Yasuo
authors: Y
authors: Shima
authors: Masayuki
authors: M
authors: Takeda
authors: Eijiro
authors: E
authors: Nagasaki
authors: Toshihiko
authors: T
authors: Nishidate
authors: Mitsue
authors: M
authors: Saito
authors: Yukino
authors: Y
authors: Ashikaga
authors: Yusuke
authors: Y
authors: Tanigawara
authors: Koichi
authors: K
authors: Hirata
authors: Chikashi
authors: C
authors: Ishioka
authors: Masahiko
authors: M
authors: Nishiyama
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D011795:Surveys and Questionnaires; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents